CAMBrachytherapyEstradiolAngiogenesisER+GuaranteedRenewableInsuranceFamilyHistory1 in 8womenPARPInhibitorsAnastrozoleAyurvedaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearStagingIntraductalPapillomaFISHDoseDenseTherapyBiopsyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BOCANeoadjuvantTherapyDimplingBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55RaloxifeneCytotoxicMultimodalityTherapyRADKi-67RatePrecisionMedicineEGFRCMFChemotherapyGailModelGeneticCounselingTyrosine-KinaseInhibitorMethotrexateWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.LumpAbsoluteRiskAlopeciaLymphNodeStatusRelapseGeneMutationDown-StagingTamoxifenHormoneReplacementTherapyCachexiaEstrogenCDK4/6InhibitorsCalcificationsApoptosisCyclophosphamideCystBreastCancerAromataseInhibitorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyLCISSERMAxillarySamplingImmunotherapyChemotherapyBevacizumabPhyllodesTumorFibroadenomaBreastTomosynthesisLumpectomyDoxorubicinTumorGradeHormoneReceptorStatusPathologicResponseAdenocarcinomaGermlineMutationOvarianSuppressionBRCAGeneTriple +/-BreastCancerMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPhysicalactivity mayreduce therisk of breastcancersChemopreventionLymphoscintigraphyCheckpointInhibitorMastectomyCytostatic5-FluorouracilDocetaxelAntibodyTherapyKappaEpsilonHER-2OligometastasesIn-situCarcinomaAdvocacyCapecitabineER-DefinitiveSurgeryECOGScorePagetDiseaseAntiemeticACChemotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinibBI-RADSAdjuvantTherapyHerceptinRadiotherapyProgestinMegestrolAcetateMetastasisPI3KinaseInhibitorsMultifocalTumorsGenomicTestingMorpheaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPaclitaxelBilateralProphylacticMastectomyPalbociclibmTORInhibitorsGeneticPredispositionSelf-examinationMRICo-survivorMastodyniaPalpationFlowCytometryCAMBrachytherapyEstradiolAngiogenesisER+GuaranteedRenewableInsuranceFamilyHistory1 in 8womenPARPInhibitorsAnastrozoleAyurvedaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearStagingIntraductalPapillomaFISHDoseDenseTherapyBiopsyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BOCANeoadjuvantTherapyDimplingBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55RaloxifeneCytotoxicMultimodalityTherapyRADKi-67RatePrecisionMedicineEGFRCMFChemotherapyGailModelGeneticCounselingTyrosine-KinaseInhibitorMethotrexateWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.LumpAbsoluteRiskAlopeciaLymphNodeStatusRelapseGeneMutationDown-StagingTamoxifenHormoneReplacementTherapyCachexiaEstrogenCDK4/6InhibitorsCalcificationsApoptosisCyclophosphamideCystBreastCancerAromataseInhibitorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyLCISSERMAxillarySamplingImmunotherapyChemotherapyBevacizumabPhyllodesTumorFibroadenomaBreastTomosynthesisLumpectomyDoxorubicinTumorGradeHormoneReceptorStatusPathologicResponseAdenocarcinomaGermlineMutationOvarianSuppressionBRCAGeneTriple +/-BreastCancerMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPhysicalactivity mayreduce therisk of breastcancersChemopreventionLymphoscintigraphyCheckpointInhibitorMastectomyCytostatic5-FluorouracilDocetaxelAntibodyTherapyKappaEpsilonHER-2OligometastasesIn-situCarcinomaAdvocacyCapecitabineER-DefinitiveSurgeryECOGScorePagetDiseaseAntiemeticACChemotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinibBI-RADSAdjuvantTherapyHerceptinRadiotherapyProgestinMegestrolAcetateMetastasisPI3KinaseInhibitorsMultifocalTumorsGenomicTestingMorpheaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPaclitaxelBilateralProphylacticMastectomyPalbociclibmTORInhibitorsGeneticPredispositionSelf-examinationMRICo-survivorMastodyniaPalpationFlowCytometry

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. CAM
  2. Brachytherapy
  3. Estradiol
  4. Angiogenesis
  5. ER+
  6. Guaranteed Renewable Insurance
  7. Family History
  8. 1 in 8 women
  9. PARP Inhibitors
  10. Anastrozole
  11. Ayurveda
  12. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  13. Staging
  14. Intraductal Papilloma
  15. FISH
  16. Dose Dense Therapy
  17. Biopsy
  18. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  19. BOCA
  20. Neoadjuvant Therapy
  21. Dimpling
  22. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  23. Raloxifene
  24. Cytotoxic
  25. Multimodality Therapy
  26. RAD
  27. Ki-67 Rate
  28. Precision Medicine
  29. EGFR
  30. CMF Chemotherapy
  31. Gail Model
  32. Genetic Counseling
  33. Tyrosine-Kinase Inhibitor
  34. Methotrexate
  35. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  36. Lump
  37. Absolute Risk
  38. Alopecia
  39. Lymph Node Status
  40. Relapse
  41. Gene Mutation
  42. Down-Staging
  43. Tamoxifen
  44. Hormone Replacement Therapy
  45. Cachexia
  46. Estrogen
  47. CDK4/6 Inhibitors
  48. Calcifications
  49. Apoptosis
  50. Cyclophosphamide
  51. Cyst
  52. Breast Cancer
  53. Aromatase Inhibitors
  54. Women ages 40+ should have a clinical breast exam at least yearly
  55. LCIS
  56. SERM
  57. Axillary Sampling
  58. Immunotherapy
  59. Chemotherapy
  60. Bevacizumab
  61. Phyllodes Tumor
  62. Fibroadenoma
  63. Breast Tomosynthesis
  64. Lumpectomy
  65. Doxorubicin
  66. Tumor Grade
  67. Hormone Receptor Status
  68. Pathologic Response
  69. Adenocarcinoma
  70. Germline Mutation
  71. Ovarian Suppression
  72. BRCA Gene
  73. Triple +/- Breast Cancer
  74. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  75. Physical activity may reduce the risk of breast cancers
  76. Chemoprevention
  77. Lymphoscintigraphy
  78. Checkpoint Inhibitor
  79. Mastectomy
  80. Cytostatic
  81. 5-Fluorouracil
  82. Docetaxel
  83. Antibody Therapy
  84. Kappa Epsilon
  85. HER-2
  86. Oligometastases
  87. In-situ Carcinoma
  88. Advocacy
  89. Capecitabine
  90. ER-
  91. Definitive Surgery
  92. ECOG Score
  93. Paget Disease
  94. Antiemetic
  95. AC Chemotherapy
  96. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  97. Lapatinib
  98. BI-RADS
  99. Adjuvant Therapy
  100. Herceptin
  101. Radiotherapy
  102. Progestin
  103. Megestrol Acetate
  104. Metastasis
  105. PI3 Kinase Inhibitors
  106. Multifocal Tumors
  107. Genomic Testing
  108. Morphea
  109. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  110. Paclitaxel
  111. Bilateral Prophylactic Mastectomy
  112. Palbociclib
  113. mTOR Inhibitors
  114. Genetic Predisposition
  115. Self-examination
  116. MRI
  117. Co-survivor
  118. Mastodynia
  119. Palpation
  120. Flow Cytometry